273 related articles for article (PubMed ID: 35223869)
1. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
2. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
[TBL] [Abstract][Full Text] [Related]
3. The prognostic and immune infiltration role of ITGB superfamily members in non-small cell lung cancer.
Wu J; Wang W; Li Z; Ye X
Am J Transl Res; 2022; 14(9):6445-6466. PubMed ID: 36247270
[TBL] [Abstract][Full Text] [Related]
4. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
Chen M; Zhu X; Zhang L; Zhao D
BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
[TBL] [Abstract][Full Text] [Related]
5. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
6. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
7. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer.
Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C
Front Oncol; 2022; 12():878546. PubMed ID: 35712475
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the prognostic value and immune infiltration of
Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
Front Oncol; 2022; 12():936952. PubMed ID: 36147913
[TBL] [Abstract][Full Text] [Related]
9. Identification of the biological functions and chemo-therapeutic responses of ITGB superfamily in ovarian cancer.
Han J; Lyu L
Discov Oncol; 2024 May; 15(1):198. PubMed ID: 38814534
[TBL] [Abstract][Full Text] [Related]
10. Tumor Endothelial Marker TEM7 is a Prognostic Biomarker and Correlating with Immune Infiltrates in Gastric Cancer.
Geng L; Chen S; Gong Y; Zhou Y; Yang H; Tang L
Int J Gen Med; 2021; 14():10155-10171. PubMed ID: 34992436
[TBL] [Abstract][Full Text] [Related]
11. GPR116 overexpression correlates with poor prognosis in gastric cancer.
Zheng T; Sun M; Liu L; Lan Y; Wang L; Lin F
Medicine (Baltimore); 2021 Dec; 100(48):e28059. PubMed ID: 35049225
[TBL] [Abstract][Full Text] [Related]
12. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
13. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
14. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
15. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
16. Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population.
Ma L; Song K; Zang J
Exp Ther Med; 2023 Nov; 26(5):532. PubMed ID: 37869645
[TBL] [Abstract][Full Text] [Related]
17. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.
Fang ZX; Hou YY; Wu Z; Wu BX; Deng Y; Wu HT; Liu J
World J Clin Oncol; 2023 Aug; 14(8):297-310. PubMed ID: 37700807
[TBL] [Abstract][Full Text] [Related]
18. LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
Ran T; Chen Z; Zhao L; Ran W; Fan J; Hong S; Yang Z
Technol Cancer Res Treat; 2021; 20():15330338211004944. PubMed ID: 33784890
[TBL] [Abstract][Full Text] [Related]
19. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
Front Genet; 2022; 13():803460. PubMed ID: 35186032
[No Abstract] [Full Text] [Related]
20. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]